Global E-Health Forum to Present Strategies, Solutions and Services

25 - 26 October 2010, Hamburg, Germany.
Healthcare systems all over the world are facing very similar challenges: demographic shifts, the impact of globalization and an increased burden of chronic diseases and expensive treatments, to mention some of the most important ones. The Global E-Health Forum will addresses these challenges. The first conference day at the Hamburg Chamber of Commerce will feature strategy and best practice presentation, workshops, discussion forums and an accompanying exhibition. The second day will be hosted by Asklepios Clinics. There, conference attendees may expect show cases, hands-on presentations and guided tours as well as a panel discussion titled "Connecting Competence for E-Health Services - What Customers Expect, What Healthcare Has to Deliver". The official reception for the international audience will take place at the U.S. Consulate General.

"Countries all over the world are facing manifold challenges regarding their healthcare delivery. Due to limited budgets and increasing demand for high-quality healthcare services, new cost-efficient, reliable and interconnected systems need to be developed", explains Ljubisav Matejevic, founder and director of the Global E-Health Forum. "This is the reason why after three Baltic Conferences on E-Health (2007-2009), we have decided to found the Global E-Health Forum," continues Ljubisav Matejevic. "E-health, meaning the application of information and communication technologies across the whole range of functions that affect the health sector, can make an important contribution to ensure a high-quality healthcare service for all citizens now and in the future.”

In keynote presentations, speakers from the U.S., Europe and New Zealand will explain their e-health strategies. Harry Reynolds, chairman of the National Committee on Vital and Health Statistics (NCVHS) and chairman of the Council for Affordable Quality Healthcare (CAQH) CORE Initiative will start this program session with his presentation titled "U.S. Health Reform: Significant Change, Varied Reaction, Opportunities Abound, and Outcome Uncertain".

The second program session will deal with best practices, for example presenting the hospital information system of Severance Cardiovascular Hospital in Seoul, South Korea. Other best practices featured will be a medical decision support system for general practitioners and interesting solutions regarding questions of quality management and process optimization.

The program will also include various breakout sessions with workshops and discussion forums where e.g. sustainable telemedicine services will be presented.

The organizers of the Global E-Health Forum - European Health Telematics Association (EHTEL), Hamburg Chamber of Commerce and IBM - have identified in Asklepios an excellent cooperation partner. Recognized as one of the most innovative leading hospital chains (the group oversees over 100 institutions, almost 40 day clinics, around 22,000 beds and 36,000 staff in Germany, Europe and the USA), Asklepios takes care of over one million patients every year. At Asklepios Clinics in Hamburg, attendees may expect more best practice solutions and hands-on experience. However, another important part will be the "services session" meaning the patients' and consumers' perspective / patient-centric e-health services. Uwe Poettgen, CIO of the Asklepios Group, will introduce this topic with a presentation entitled "Connecting Competence for E-Health Services - What Customers Expect, What Healthcare Has to Deliver".

The primary aim of the English-language conference is to provide a cross-sector forum for approximately 200 representatives from hospitals and clinics, governments, health insurance organizations, service providers and the media. Policymakers, users, suppliers and implementation managers will have the opportunity to exchange views and experiences among all those involved in health management. The impact of globalization on healthcare systems and services will be discussed as well as the resulting requirements regarding interconnectivity, interoperability and standardization as well as the need for cross border co-operation.

Among the supporters of this year's conference are the European Association of Healthcare IT Managers, Koch-Mechnikov-Forum, German Hospital Society, U.S. Commercial Service, Finpro, Business Institute (Croatia), and FOM University of Applied Sciences.

For further information and registration, please visit:
http://www.global-ehealth-forum.com

Most Popular Now

Sanofi to acquire Ablynx for €3.9 Billion

Sanofi and Ablynx, a biopharmaceutical company engaged in the discovery and development of Nanobodies®, entered into a definitive agreement under which Sanofi will offer ...

In wine, there's health: Low levels of alcohol goo…

While a couple of glasses of wine can help clear the mind after a busy day, new research shows that it may actually help clean the mind as well. The new study, which appe...

Repurposed drug found to be effective against Zika…

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmiss...

More stroke patients may receive crucial treatment…

More patients could be eligible for critical treatments to remove or dissolve blood clots that cause strokes, according to a new treatment guideline issued by the America...

Interim publications of randomized trials make new…

Early results from randomized trials are sometimes published before the trial is completed. The results of such interim publications may generate a great deal of interest...

Drug trial protocol redactions by industry sponsor…

New research published by the Journal of the Royal Society of Medicine exposes the extent of redactions in protocols for industry-sponsored randomised drug trials. Trial ...

Advanced Accelerator Applications receives FDA ap…

Novartis AG (NYSE: NVS) announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug Administration (FDA) approva...

Blood vessel-on-a-chips show anti-cancer drug effe…

Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel ...

Roche reports good results in 2017

In 2017, Group sales rose 5% to CHF 53.3 billion. Core operating profit grew 3% and Core EPS increased 5%, reflecting the good underlying business performance. On an IFRS...

FDA approves new treatment for certain digestive t…

The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointesti...

Cells of 3 advanced cancers die with drug-like com…

Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggres...

Pfizer announces positive top-line results for pot…

Pfizer Inc. has announced that REFLECTIONS B3281006, a comparative safety and efficacy study of PF-05280586 versus MabThera® (rituximab-EU), met its primary endpoint. PF-...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]